Completed PHASE3 INTERVENTIONAL NCT00351182

Controlled Trial: 5-day Course of Telithromycin Versus Doxycycline for the Treatment of Mild to Moderate Scrub Typhus

Phase 3 Study of Controlled Trial: 5-day Course of Telithromycin Versus Doxycycline for the Treatment of Mild to Moderate Scrub Typhus

Sponsor: Dong-Min Kim

Conditions Scrub Typhus

Interventions Doxycycline Telithromycin

Updated 6 times since 2017 Last updated: Feb 6, 2019 Started: Sep 30, 2005 Primary completion: Dec 31, 2005 Completion: Dec 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00351182, this PHASE3 trial focuses on Scrub Typhus and remains completed. Sponsored by Dong-Min Kim, it has been updated 6 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Mar 2019 — Jan 2021 [monthly]

Completed PHASE3

Status: Unknown Status → Completed

▶ Show 1 earlier version

Jan 2017 — Mar 2019 [monthly]

Unknown Status PHASE3

First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dong-Min Kim

Data source: Chosun University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gwangju, South Korea